Vanda Pharma Files Proxy Supplement
Ticker: VNDA · Form: DEFA14A · Filed: May 27, 2025 · CIK: 1347178
| Field | Detail |
|---|---|
| Company | Vanda Pharmaceuticals Inc. (VNDA) |
| Form Type | DEFA14A |
| Filed Date | May 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, proxy-statement, pharmaceuticals
TL;DR
Vanda Pharma dropped more proxy docs, check the latest filings.
AI Summary
Vanda Pharmaceuticals Inc. filed a Definitive Additional Materials filing (DEFA14A) on May 27, 2025. This filing supplements previous proxy materials. The company, incorporated in Delaware with its principal office in Washington D.C., operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates ongoing corporate actions and communications with shareholders, which can impact investor decisions and company governance.
Risk Assessment
Risk Level: low — This is a routine SEC filing (DEFA14A) related to proxy materials, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- Vanda Pharmaceuticals Inc. (company) — Registrant
- 20250527 (date) — Filing Date
- 20037 (zip_code) — Business and Mail Address Zip Code
- 2834 (sic_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What type of SEC filing is this?
This is a DEFA14A filing, specifically marked as Definitive Additional Materials.
Who is the registrant for this filing?
The registrant is Vanda Pharmaceuticals Inc.
On what date was this filing made?
The filing was made on May 27, 2025.
What is Vanda Pharmaceuticals Inc.'s Standard Industrial Classification code?
Vanda Pharmaceuticals Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Vanda Pharmaceuticals Inc. located?
Vanda Pharmaceuticals Inc.'s business and mail address is in Washington D.C., with a zip code of 20037.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 27, 2025 regarding Vanda Pharmaceuticals Inc. (VNDA).